Results 201 to 210 of about 114,798 (264)

Tryptophan Ameliorates Metabolic Syndrome by Inhibiting Intestinal Farnesoid X Receptor Signaling: The Role of Gut Microbiota-Bile Acid Crosstalk. [PDF]

Research (Wash D C)
Chen J, Yang H, Qin Y, Zhou X, Ma Q.
europepmc   +1 more source

Bidirectional interaction between farnesoid X Receptor and MicroRNAs

, 2016
openaire   +2 more sources

Glucagon-like peptide-2 pharmacotherapy activates hepatic Farnesoid X receptor-signaling to attenuate resection-associated bile acid loss in mice. [PDF]

Mol Metab
Reiner J, Mohebali N, Kurth J, Witte M, Prehn C, Lindner T, Berlin P, Elleisy N, Förster RH, Cecil A, Jaster R, Adamski J, Schwarzenböck SM, Vollmar B, Krause BJ, Lamprecht G.   +15 more
europepmc   +1 more source

Lactobacillus rhamnosus GG maintains gut microbiota stability and promotes intestinal adaptation via activated intestinal farnesoid X receptor signaling in short bowel syndrome. [PDF]

Commun Biol
Gui L, Duan X, Wang H, Xie H, Zhang R, Jiang W, Tang W.   +6 more
europepmc   +1 more source

Role of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. [PDF]

touchREV Endocrinol
Kamrul-Hasan A, Mondal S, Nagendra L, Sasikanth T, Ahammed A, Rahman S, Wickramarachchi A, Parajuli N, Khatiwada S, Dutta D.   +9 more
europepmc   +1 more source

On the Cholesterol Raising Effect of Coffee Diterpenes Cafestol and 16-O-Methylcafestol: Interaction with Farnesoid X Receptor. [PDF]

Int J Mol Sci
Guercia E, Berti F, De Zorzi R, Navarini L, Geremia S, Medagli B, De Conto M, Cassetta A, Forzato C.   +8 more
europepmc   +1 more source

Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cancer cells. [PDF]

World J Gastroenterol
Liu CX, Gao Y, Xu XF, Jin X, Zhang Y, Xu Q, Ding HX, Li BJ, Du FK, Li LC, Zhong MW, Zhu JK, Zhang GY.   +12 more
europepmc   +1 more source

Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice. [PDF]

Int J Mol Sci
Yang CW, Liu HM, Chang ZY, Liu GH, Chang HH, Huang PY, Lee TY.   +6 more
europepmc   +1 more source

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment. [PDF]

Acta Pharm Sin B
Fu J, Zhang P, Sun Z, Lu G, Cao Q, Chen Y, Wu W, Zhang J, Zhuang C, Sheng C, Xu J, Lu Y, Wang P.   +12 more
europepmc   +1 more source

Total Iridoid Glycosides from Swertia mussotii Franch. Alleviate Cholestasis Induced by α-Naphthyl Isothiocyanate through Activating the Farnesoid X Receptor and Inhibiting Oxidative Stress. [PDF]

Int J Mol Sci
Dong Q, Wang Z, Hu N, Tie F, Liu Z, Sun Y, Wang Y, Tan N, Wang H.   +8 more
europepmc   +1 more source